Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma
Yasuyuki Mizutani(Nagoya University), Mitsuhiro Fujishiro(Bunkyo University), Eizaburo Ohno(Nagoya University), Tadashi Iida(Nagoya University), Miwa Imai(Nagoya University Hospital), Hiroki Kawashima(Nagoya University Hospital), Fumie Kinoshita(Nagoya University Hospital), Yachiyo Kuwatsuka(Nagoya University Hospital), Takuya Ishikawa(Nagoya University), Shinobu Shimizu(Nagoya University Hospital), Toshihisa Tsuruta(Nagoya University Hospital), Atsushi Enomoto(Nagoya University)
Cited by 32
Related Papers
Application of artificial intelligence using a convolutional neural network for detecting gastric cancer in endoscopic images
|Gastric Cancer|2018|742
Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer
|Digestive Endoscopy|2015|575
Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition)
|Digestive Endoscopy|2020|510
Diagnostic outcomes of esophageal cancer by artificial intelligence using convolutional neural networks
|Gastrointestinal Endoscopy|2018|470
Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment
|Digestive Endoscopy|2013|469